Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.38 |
| ▸ | STAT3 | P40763 | 8/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL419331 | 0.98 | ELANE (0.41) | ELANEL3MBTL1PTPN1STAT3MEN1 | |
| SCHEMBL424543 | 0.96 | ELANE (0.44) | ELANEL3MBTL1PTPN1STAT3MEN1 | |
| SCHEMBL422234 | 0.94 | ELANE (0.41) | ELANEL3MBTL1PTPN1STAT3MEN1 | |
| SCHEMBL421492 | 0.89 | ELANE (0.47) | ELANEL3MBTL1PTPN1STAT3MEN1 | |
| Paederoside SCHEMBL422181 | 0.88 | STAT3 (0.41) | ELANEL3MBTL1PTPN1STAT3MEN1 | |
| SCHEMBL424407 | 0.83 | MAPT (0.44) | ELANEL3MBTL1PTPN1STAT3MEN1 | |
| SCHEMBL29425847 | 0.81 | ELANE (0.53) | ELANESTAT3MEN1MAPTKMT2A | |
| SCHEMBL28912673 | 0.81 | ELANE (0.53) | ELANESTAT3MEN1MAPTKMT2A | |
| SCHEMBL423645 | 0.80 | ELANE (0.46) | ELANEL3MBTL1PTPN1STAT3MEN1 | |
| Deacetylasperuloside SCHEMBL29367563 | 0.80 | L3MBTL1 (0.53) | ELANEL3MBTL1PTPN1STAT3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3409766-B1 | AN ESTERASE THAT IS CAPABLE OF CONVERTING IRIDOIDS AND SECO-IRIDOIDS | N ZYME BIOTEC GMBH (DE) | 2022-03-09 | — | — | EP | disclosed |